干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
干细胞之家 - 中国干细胞行业门户第一站 干细胞之家论坛 干细胞行业新闻 人MSCs促进小鼠MS修复的分子机制(附原文)
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 23409|回复: 5
go

人MSCs促进小鼠MS修复的分子机制(附原文) [复制链接]

Rank: 3Rank: 3

积分
331 
威望
331  
包包
218  

优秀会员

楼主
发表于 2012-7-3 07:36 |只看该作者 |倒序浏览 |打印
本帖最后由 细胞海洋 于 2012-7-5 23:24 编辑 / x: A; D$ h8 d" v, P- L0 F- D
. J0 n" x) h$ _' D7 w
Could Stem Cells Cure MS?
2 K/ g; _$ y7 |2 o7 Q6 VA growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.
( k- O9 s0 w1 a' U/ `8 Q
% B" H3 U. E# i& F# ~4 W0 yBy Megan Scudellari | May 23, 2012 / W6 \4 f! i& {1 x' x

2 H. C8 b3 V& r6 x8 B A human mesenchymal stem cell
9 }. e& g5 h. K  n% I) K2 HWikimedia Commons, GhansonHuman mesenchymal stem cells (hMSCs) have become a popular potential therapy for numerous autoimmune and neurological disorders. But while these bone marrow-derived stem cells have been studied in great detail in the dish, scientists know little about how they modulate the immune system and promote tissue repair in living organisms.+ T! |9 e3 }6 S0 F8 l( D
4 `$ R# e$ F) r
Now, one research team has uncovered a molecular mechanism by which hMSCs promote recovery in a mouse model of multiple sclerosis (MS).' d/ g3 [$ L" k0 p

* M$ A8 s; v* N' S  W! l7 J/ jAccording to research, published online Sunday (May 20) in Nature Neuroscience, a growth factor produced by hMSCs fights MS in two ways: blocking a destructive autoimmune response and repairing neuronal damage. The finding could help advance ongoing clinical trials testing hMSCs as a therapy for MS.7 ^& i: @) ^7 F4 K# f& s: e; N
8 C! z: t" V& `6 e2 p
The researchers have identified “a unique factor that has surprisingly potent activity mediating neuron repair,” said Jacques Galipeau, a cell therapy researcher at Emory University in Atlanta, Georgia, who was not involved in the research. “The magnitude of the effect on a mouse model of MS is a big deal.”9 s1 W2 n2 d/ j' _8 ]
: O% a7 {5 U- ?' k8 Z6 m
MS is an autoimmune disease in which the immune system attacks myelin sheaths that surround and protect nerve cells. The attack leaves nerves exposed and unable to send signals to the brain and back, resulting in the loss of motor skills, coordination, vision, and cognitive abilities. There is no cure for MS, and most current therapies work to simply suppress the immune system, preventing further neuronal damage. None have demonstrated an ability to also repair damaged myelin and promote recovery.% ~( K& a0 e. N% _5 W7 Y
2 e. b3 ?6 d" U7 A7 ~8 F
In 2009, Robert Miller and colleagues at Case Western Reserve University in Cleveland, Ohio, demonstrated that hMSCs dramatically reversed the symptoms of multiple sclerosis in a mouse model of the disorder. “The animals got better,” recalled Miller. The team hypothesized that the stem cells suppress the immune response and promote remyelination.
& y1 c+ M  ~$ u/ A, L' n  |) L$ ]% e
. ~5 m% Z3 q6 ?  M5 n1 m& U$ [But Miller wanted to know exactly what the cells were doing. To find out, his team isolated the medium on which the hMSCs were grown to determine if the cells or something they secreted was responsible for the observed recovery. The medium alone was enough to induce recovery in mice, pointing to the latter.$ z+ H5 X2 [4 K* ]5 T+ p) z
" ?) t& K) K+ V! t2 ]6 F
To find out exactly which molecule or molecules in the medium were responsible, the researchers separated the proteins in the fluid based on the molecular weight and injected each isolate into mice exhibiting symptoms of MS. The mid-weight solution, of proteins with masses between 50 and 100 kilodaltons (kDa), caused recovery. “That eliminated a huge number of potential candidates,” said Miller., ~1 E) X* N/ C, U7 l5 S6 I
2 K1 U, L, V5 w6 T
The researchers then narrowed the field again with a literature search for a molecule that fit their criteria: secreted by hMSCs, 50-100 kDa in size, and involved in tissue repair. They identified hepatocyte growth factor (HGF), a cytokine made by mesenchymal cells that has been shown to promote tissue regeneration and cell survival in numerous experiments. Sure enough, HGF alone was enough to promote recovery in the MS mouse models, and blocking the receptor for HGF in those mice blocked recovery. The team also demonstrated that HGF suppresses immune responses in vivo and accelerates remyelination of neurons in vitro. Finally, they saw that HGF causes remyelination in rats with a lesion on their spinal cord.7 \2 i- k6 M* T: m: {
% ~( K1 ]+ k, |6 H
“I feel quite confident that HGF suppresses the immune response and also drives myelin repair,” said Miller. There are likely other hMSCs-produced factors that contribute to the cells’ beneficial effect, but HGF is certainly critical, he said. “The data are compelling,” added Galipeau.
# H% B4 t  i9 x* U
5 m7 `* F4 ]  w9 iThere are currently several clinical trials testing hMSCs in MS patients around the world, including a phase I trial at the Cleveland Clinic in Ohio that emerged from the work in Miller’s lab. The new mechanistic information could help researchers designing those therapies to select cells that produce high levels of HGF, said Miller, which should promote remyelination and maximize symptom reversal.
  X  R. K% K' r
+ D# I2 u7 ?) }+ {) ^% qBut the research begs a question: why not simply forgo the cells altogether? That point is up for debate. Miller argues that stem cells act as vehicles to transport HGF, and other potential factors, directly to the central nervous system and maintain production there. But a single protein is a far more practical therapy—cheaper and easier to produce—than a cell therapy, countered Galipeau. “The best cell therapy is one done without a cell,” he said. “Identifying these factors and testing them as single agents is an important short-term deliverable of stem cell science.”
$ F+ g) P: P, X; n+ B$ D# H6 H
! w; K, K  H$ {" S6 zTo find out more about which cell therapies are in clinical trials, stay tuned for the July issue of The Scientist, featuring an analysis of the growing cell therapy industry.
. m, Q& d' p' \3 \2 z
5 O7 u- L5 D; a! J9 a! g' Q3 rL. Bai et al., “Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models,” Nat Neuro, doi:10.1038/nn.3109, 2012.
" V  E2 @% d, s
1 j  @$ a$ m& I% K) ?1 ~- C4 N( }0 r2 o9 H; a
5楼原文 感谢naturalkillerce 提供
已有 1 人评分威望 包包 收起 理由
细胞海洋 + 2 + 10 极好资料

总评分: 威望 + 2  包包 + 10   查看全部评分

Rank: 3Rank: 3

积分
947 
威望
947  
包包
7  

金话筒 优秀会员

沙发
发表于 2012-7-3 17:51 |只看该作者
谁有全文啊?

Rank: 1

积分
威望
2  
包包
11  
藤椅
发表于 2012-7-4 23:14 |只看该作者
我也想要全文 我刚好做这方面的实验

Rank: 7Rank: 7Rank: 7

积分
6084 
威望
6084  
包包
18316  

优秀版主 金话筒 优秀会员

板凳
发表于 2012-7-5 09:06 |只看该作者
干细胞之家微信公众号
本帖最后由 naturalkillerce 于 2012-7-5 09:06 编辑
) T# O# s7 D2 T2 C1 [1 G1 L5 x- [- J# ^; U' o# ~  `: a
回复 tinatina 的帖子
0 ^: w+ P* w! b
  L9 Y& @6 j0 v- ?3 R人间质干细胞释放的肝细胞生长因子有望治疗多发性硬化症7 B2 R/ N" G) m# Z8 p" M
时间:2012-05-23 08:41:54 来源:生物无忧 作者:davidtower+ E$ ^, p( {( R' l

$ G+ [2 {) _, @6 U! K" a" [来自美国凯斯西储大学(Case Western Reserve University)医学院的研究人员发现,促进生长的人间充质干细胞(human mesenchymal stem cell, hMSC)释放的肝细胞生长因子似乎能够促进多发性硬化症(multiple sclerosis, MS)啮齿类模式动物神经复原及其功能恢复.相关研究结果于2012年5月20日在线发表在Nature Neuroscience期刊上,论文标题为"Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models".0 Q' w7 x  i1 B

+ ~5 }( M! h0 _% P/ V  f# G3 n 当把肝细胞生长因子注射到动物体内时,炎症减少,神经细胞生长.也许最重要的是,保护神经和能够收集和发送信息的髓鞘再次生长,从而覆盖多发性硬化症产生的损伤部位.
9 o6 |. X, u+ B% F% N1 S$ R7 n# d2 D+ t/ M9 r' [5 @( @. l
凯斯西储大学研究副主席和该大学医学院神经科学教授Robert H. Miller说,"这项研究的重要性在于我们鉴定出促进神经功能恢复的促进物."
  I. b+ y' _3 v# G* b* D/ l! F& ?7 t+ o
    在患上多发性硬化症时,免疫系统攻击髓鞘,让暴露出来的错综复杂的神经线路冒着遭受损伤的风险.当遭受损伤时,神经信号传递被中断,从而导致平衡、协调和认知能力以及其他功能缺失.随着时间的推移,间歇性的损失可能会变成永久性的.; g4 X; G6 \5 R

' F0 ?  }8 n) z    2009年,Miller和Caplan曾报道,当他们把人间充质干细胞注射进多发性硬化症啮齿类模式动物体内时,这些动物从这种疾病导致的损伤中恢复过来.基于他们的研究,一次临床试验正在开展当中,在试验中,将来自多发性硬化症病人自己的干细胞注射到他们自己的体内.
( q. I) P% c3 s2 X) ?: g- {" O& T4 |9 x: t: Y6 c$ s4 Z
    在这项研究中,研究人员首先想要测试是否干细胞的存在或这些细胞产生的物质是否促进恢复.他们将培养过来自人骨髓的间充质干细胞的培养基注射进小鼠体内.结果全部患有一种多发性硬化症的11只小鼠显示出功能障碍快速减少.进行分析后还表明,除非注射进小鼠体内的分子具备一定分子量(即位于50 kDa到100kDa之间),否则这种疾病仍然继续发展.+ d# j- |3 W3 `: z2 {; N7 p

+ c( E2 f4 p: H/ d- z    研究人员自己的研究和其他人的研究表明间充质干细胞分泌出的肝细胞生长因子可能就是这种促进物.
1 t# [: H  c& {$ {# N' \+ Y$ ~, F# \8 f
    研究人员每隔一天注射50或100毫微克这种生长因子到小鼠体内,并持续5天.促进炎症产生的信号分子水平下降,而对抗炎症的信号分子水平上升.神经细胞进行生长,而且由多发性硬化症产生的裸露神经线路再次被髓鞘遮盖住.注射100毫微克生长因子似乎提供稍好一些的恢复.
$ U( h9 [: T# I* L; l
' K  E6 ~9 C# g    为了进一步对系统进行测试,研究人员阻断细胞表面受体,在这项研究中,就是cMet受体,已知这种受体与肝细胞生长因子一起发挥作用.
! ~7 G% P4 d& z/ N3 J+ F% Y  [1 E$ f* B& p# V. d3 m$ D
    当他们利用阻断cMet功能的抗体堵住这种受体时,无论是注射间充质干细胞培养基还是注射肝细胞生长因子都不对这种疾病产生任何影响.在另一项测试中,注射抗肝细胞生长因子抗体到小鼠体内也会阻止神经功能恢复.
$ y' w, N6 {. C' G* ^
! {$ N3 Y" u% X( A    研究人员将继续开展他们的研究,以确定他们是否可以筛选出哪些间充质干细胞能够产生开展有效治疗所必需的较高浓度的肝细胞生长因子.这可能会导致人们开发出一种更加精准的细胞疗法.0 z, D1 Q  e5 O

1 J) W2 N, Y* b7 U& @- ]4 u    Miller说,"我们如今能够不使用间充质干细胞,而只用肝细胞生长因子来治疗吗?我们已证实在一种动物中我们确实可以这样做,但是仍不清楚在多发性硬化症病人中我们是否也能够这样开展治疗."
! z  i- m9 t! r  g( K/ k2 H( H. f$ S/ i% l8 c1 X
    他们还计划测试是否也可以利用其他因子刺激cMet受体和诱导恢复.
已有 1 人评分威望 包包 收起 理由
细胞海洋 + 2 + 10 极好资料

总评分: 威望 + 2  包包 + 10   查看全部评分

Rank: 7Rank: 7Rank: 7

积分
6084 
威望
6084  
包包
18316  

优秀版主 金话筒 优秀会员

报纸
发表于 2012-7-5 11:31 |只看该作者
回复 lidan632496974 的帖子0 m7 L; z; G, _# O

  \& V' J, b3 T  z- Y% x
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
已有 1 人评分威望 包包 收起 理由
细胞海洋 + 2 + 10 极好资料

总评分: 威望 + 2  包包 + 10   查看全部评分

Rank: 2

积分
94 
威望
94  
包包
3  
地板
发表于 2012-7-5 21:13 |只看该作者
收藏学习
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2025-5-2 20:28

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.